Copyright
©The Author(s) 2021.
World J Hepatol. Oct 27, 2021; 13(10): 1289-1298
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1289
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1289
Table 1 Commonly accepted acute-on-chronic liver failure definitions
APASL | EASL | NASCELD | |
Definition | An acute hepatic insult manifesting as jaundice (serum bilirubin ≥ 5 mg/dL) and coagulopathy (INR ≥ 1.5) complicated within 4 wk by clinical ascites and/or encephalopathy in a patient with previously diagnosed or undiagnosed chronic liver disease/cirrhosis, and is associated with a high 28-d mortality | An acute deterioration of pre-existing chronic liver disease usually related to a precipitating event and associated with increased mortality at 3 mo due to multisystem organ failure | A syndrome characterized by acute deterioration of cirrhosis with two or more extrahepatic organ failure |
Included patients | Acute liver deterioration in patients with previously diagnosed or undiagnosed chronic liver disease including cirrhosis. Acute hepatic triggering factors | Cirrhosis (compensated or decompensated) | Cirrhosis (compensated or decompensated) |
Renal failure is mandatory | Two extrahepatic organ failure | ||
Patients with an acute decompensation of cirrhosis | Presentation not necessarily to be liver failure | ||
Patients with prior decompensation of cirrhosis | Can be repeated episodes of ACLF | ||
Excluded patients | Patients with bacterial infections | HCC | HIV infection |
Patients with cirrhosis who develop acute deterioration of their clinical status are considered to have acute decompensation but not ACLF | HIV infection | Disseminated malignancies | |
Prior decompensation.Non-hepatic acute insults (such as sepsis) | Receiving immunosuppressive treatments | ||
Pediatric definition | For children less than 3 years, modified HE assessment scale can be used | None | None |
Clinical and/or radiological ascites can be used for defining ACLF in children |
Table 2 Chronic liver failure–sequential organ failure assessment score
Organ/systems | 0 | 1 | 2 | 3 | 4 |
Liver (bilirubin, mg/dL) | < 1.2 | ≥ 1.2 to < 2.0 | ≥ 2.0 to < 6.0 | ≥ 6.0 to < 12.0 | ≥ 12.0 |
Kidney (creatinine, mg/dL) | < 1.2 | ≥ 1.2 to < 2.0 | ≥ 2.0 to < 3.5 | ≥ 3.5 to < 5.0(or RRT) | ≥ 5.0(or RRT) |
Cerebral (HE grade) | No HE | I | II | III | IV |
Coagulation (INR) | < 1.1 | ≥ 1.1 to < 1.25 | ≥ 1.25 to < 1.5 | ≥ 1.5 to < 2.5 | ≥ 2.5 or platelet < 20 × 109 /L |
Circulation (mean arterial pressure, mm Hg) | ≥ 70 | < 70 | Dopamine ≤ 5 or dobutamine or terlipressin(µg/kg/min) | Dopamine > 5 or E ≤ 0.1 or NE ≤ 0.1(µg/kg/min) | Dopamine > 15 or E > 0.1 or NE > 0.1(µg/kg/min) |
Lungs | |||||
PaO/FiO2 | > 400 | > 300 to ≤ 400 | > 200 to ≤ 300 | > 100 to ≤ 200 | ≤ 100 |
or SpO2/FiO2 | > 512 | > 357 to ≤ 512 | > 214 to ≤3 57 | < 89 to ≤ 214 | ≤ 89 |
Table 3 Asian Pacific Association for the Study of the Liver Acute-on-Chronic Liver Failure score
Points | Total bilirubin (mg/dL) | HE grade | INR | Lactate (mmol/L) | Creatinine (mg/dL) |
1 | < 15 | 0 | < 1.8 | < 1.5 | < 0.7 |
2 | 15-25 | I-II | 1.8-2.5 | 1.5-2.5 | 0.7-1.5 |
3 | > 25 | III-IV | > 2.5 | > 2.5 | > 1.5 |
Table 4 Modified chronic liver failure–sequential organ failure assessment score
Organ/systems | 0 | 1 | 2 | 3 | 4 |
Liver (bilirubin, mg/dL) | < 1.2 | ≥ 1.2 to < 2.0 | ≥ 2.0 to < 6.0 | ≥ 6.0 to < 12.0 | ≥ 12.0 |
Kidney (creatinine, rise from baseline) | < 1.5 × | 1.5 to ≤ 2.0 × | > 2.0 to ≤ 3 × | > 3 × | Need for RRT |
Cerebral (HE grade) | 0 | I | II | III | IV |
Coagulation (INR) | < 1.1 | ≥ 1.1 to ≤ 1.25 | > 1.25 to < 1.5 | ≥ 1.5 to ≤ 2.5 | > 2.5 |
Circulation (systolic BP) | Normal for age | < 5th centile for age | NE < 0.5 µg/kg/min | NE > 0.5 µg/kg/min | NE > 0.5 µg/kg/min and 2nd inotrope |
Lungs | |||||
PaO/FiO2 | > 400 | > 300 to ≤ 400 | > 200 to ≤ 300 | > 100 to ≤ 200 | ≤ 100 |
Table 5 Modified Asian Pacific Association for the Study of the Liver Acute-on-Chronic Liver Failure score
Points | Total bilirubin (mg/dL) | HE grade | INR | Lactate (mmol/L) | Creatinine (rise from baseline) |
1 | < 15 | 0 | < 1.8 | < 1.5 | < 1.5 × |
2 | 15-25 | I-II | 1.8-2.5 | 1.5-2.5 | 1.5 to ≤ 3 × |
3 | > 25 | III-IV | > 2.5 | > 2.5 | > 3 × or need RRT |
- Citation: Islek A, Tumgor G. Acute-on-chronic liver failure in children. World J Hepatol 2021; 13(10): 1289-1298
- URL: https://www.wjgnet.com/1948-5182/full/v13/i10/1289.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i10.1289